In this work, we propose an extensive protocol for the using of CRISPRi technology to downregulate Rnd3 expression in RPMI 8226 and JJN3 MM cell lines, by using lentiviral vectors and specific RND3 sgRNA. The gene discussed is RND3; the disease is Miyoshi myopathy.